Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 225,206,853 papers from all fields of science
Search
Sign In
Create Free Account
APO 866
Known as:
APO-866
, APO866
, NMPRTase Inhibitor APO866
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
2 relations
Broader (2)
Daporinad
Enzyme Inhibitors
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Induction of Apoptosis and Autophagy By Nampt Inhibition in Adult T-Cell Leukemia/Lymphoma and Leukemic Cell Lines
T. Kozako
,
M. Yoshimitsu
,
+4 authors
S. Soeda
2016
Corpus ID: 208480411
Introduction: Adult T-cell leukemia/lymphoma (ATL) is an aggressive peripheral T-cell neoplasm that develops after long-term…
Expand
2015
2015
Combinative effects of β-Lapachone and APO866 on pancreatic cancer cell death through reactive oxygen species production and PARP-1 activation.
Caroline S Breton
,
D. Aubry
,
+5 authors
A. Nahimana
Biochimie
2015
Corpus ID: 9977357
2015
2015
A multicenter, open label, phase II study to assess the efficacy and safety of APO866 in the treatment of patients with refractory or relapsed cutaneous T-cell lymphoma.
S. Goldinger
,
S. Gobbi
,
+7 authors
R. Dummer
2015
Corpus ID: 78770729
e20044 Background: Cutaneous T-cell lymphoma (CTCL) is characterized by the accumulation of clonal T-cells in the skin. Given the…
Expand
2014
2014
NAD⁺ depletion by APO866 in combination with radiation in a prostate cancer model, results from an in vitro and in vivo study.
S. Zerp
,
C. Vens
,
B. Floot
,
M. Verheij
,
B. van Triest
Radiotherapy and Oncology
2014
Corpus ID: 39221570
2014
2014
The anti-lymphoma activity of APO866, an inhibitor of nicotinamide adenine dinucleotide biosynthesis, is potentialized when used in combination with anti-CD20 antibody
A. Nahimana
,
D. Aubry
,
+4 authors
M. Duchosal
Leukemia and Lymphoma
2014
Corpus ID: 42792745
Abstract APO866 is an inhibitor of nicotinamide adenine dinucleotide (NAD) biosynthesis that exhibits potent anti-lymphoma…
Expand
2013
2013
[18F]FLT and [18F]FDG PET for Non-invasive Treatment Monitoring of the Nicotinamide Phosphoribosyltransferase Inhibitor APO866 in Human Xenografts
Mette Munk Jensen
,
K. Erichsen
,
+7 authors
A. Kjær
PLoS ONE
2013
Corpus ID: 15552680
Introduction APO866 is a new anti-tumor compound inhibiting nicotinamide phosphoribosyltransferase (NAMPT). APO866 has an anti…
Expand
2013
2013
AB0131 NAMPT/VISFATIN in osteoarthritis: An adipokine involved in the communication between cartilage and bone
Marie-Charlotte Laiguillon
,
C. Bougault
,
+7 authors
J. Sellam
2013
Corpus ID: 75905116
Background It has been recently demonstrated that a pro-inflammatory adipokine called visfatin can be produced by chondrocytes in…
Expand
2012
2012
74 Synergistic Interaction Between P-glycoprotein Inhibitors and APO866 in Primary Leukemic Cells
D. Soncini
,
S. Bruzzone
,
+5 authors
A. Nencioni
2012
Corpus ID: 58021120
2011
2011
Pre-B Cell Colony-Enhancing Factor (PBEF/Nampt/Visfatin) Primes Neutrophils for Augmented Respiratory Burst Activity through Partial Assembly of the NADPH Oxidase
Z. Malam
,
J. Parodo
,
Faiza Waheed
,
K. Szászi
,
A. Kapus
,
J. Marshall
Journal of Immunology
2011
Corpus ID: 23932577
Pre-B cell colony-enhancing factor ([PBEF] also known as Nampt/visfatin) is a pleiotropic 52-kDa cytokine-like molecule whose…
Expand
2009
2009
Recipient plasmacytoid DCs are not required to prime allogeneic T-cell responses after BMT.
K. Markey
,
K. Macdonald
,
G. Hill
Blood
2009
Corpus ID: 206879823
To the editor: We read with interest the elegant studies of Koyama and colleagues[1][1] in which they demonstrate the ability of…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE